ArticleBreast cancer research : BCR2026
Risk factors for ductal carcinoma in situ: comparisons with invasive breast cancer.
Article in Breast cancer research : BCR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundDuctal carcinoma in situ (DCIS) is a precursor of invasive breast cancer; however, the majority of DCIS tumors do not progress to invasive breast cancer. Elucidating shared and distinct risk factors for DCIS and invasive breast cancer may provide novel insights into the pathogenesis of breast cancer.
methodsThe Multiethnic Cohort Study was used to examine whether known risk factors for invasive breast cancer are associated with DCIS among a racially and ethnically diverse U.S. population of women.
resultsAfrican American (HR 1.49, 95% CI 1.24-1.78), Native Hawaiian (HR 1.50, 95% CI 1.19-1.88), and Japanese American (HR 1.66, 95% CI 1.43-1.94) women were found to have a significantly higher risk of DCIS compared to White women, with Latino women having a non-significant increased risk (HR 1.19, 95% CI 0.97-1.48). Of the risk factors we investigated, increased risk of DCIS was associated with family history of breast cancer (HR 1.55, 95% CI 1.34-1.79), Type 2 diabetes (HR 1.27, 95% CI 1.09-1.48), nulliparity (HR 1.36, 95% CI 1.15-1.62), older age (> 30 yrs) at first live birth (p-trend 0.001), and current use of estrogen hormone therapy with or without progesterone (HR 1.19, 95% CI 1.04-1.35; HR 1.18, 95% CI 1.02-1.38, respectively). Decreased risk of DCIS was associated with parity, with a p-trend = 0.0001 for increasing number of children, and non-U.S. birthplace (HR 0.78, 95% CI 0.66-0.93). Risk factor associations did not differ significantly across racial and ethnic groups, with the exception of smoking status (p-het = 0.05), where an increased risk was found only for Native Hawaiians.
conclusionThe identification of both shared and distinct risk factors of DCIS and invasive breast cancer underscores the need for other methods for risk stratification to differentiate indolent DCIS tumors from aggressive precursor lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.